June 2012
You are browsing the archive for June 2012.
1,000th designation of an orphan medicinal product: improving the lives of patients
European Commission – Press Release, June 07, 2012
Orphan medicines relate to diseases which affect not more than 5 persons in 10.000 in the EU. As a consequence, the economic potential of such medicines is very limited which hampers the development of new medicines. In response, the EU adopted dedicated legislation…..
